|
Volumn 84, Issue 10, 2013, Pages 1068-1074
|
Disease course and outcome of 15 monocentrically treated natalizumab-associated progressive multifocal leukoencephalopathy patients
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AZATHIOPRINE;
BETA1A INTERFERON;
CLONAZEPAM;
CORTICOSTEROID;
ETIRACETAM;
FINGOLIMOD;
GLATIRAMER;
HARKOSERIDE;
IMMUNOGLOBULIN;
INTERFERON BETA SERINE;
LAMOTRIGINE;
LORAZEPAM;
MANNITOL;
MEFLOQUINE;
METHYLPREDNISOLONE;
MIRTAZAPINE;
MITOXANTRONE;
NATALIZUMAB;
TOPIRAMATE;
VIRUS DNA;
ADULT;
ARTICLE;
BRAIN EDEMA;
CEREBROSPINAL FLUID ANALYSIS;
CLINICAL ARTICLE;
DISEASE COURSE;
DRUG DOSE INCREASE;
DRUG EXPOSURE;
DRUG MEGADOSE;
DRUG WITHDRAWAL;
EXPANDED DISABILITY STATUS SCALE;
FEMALE;
HUMAN;
IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME;
IMMUNOADSORPTION;
JC VIRUS;
KARNOFSKY PERFORMANCE STATUS;
LOADING DRUG DOSE;
MALE;
MULTIPLE SCLEROSIS;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PLASMAPHERESIS;
PRIORITY JOURNAL;
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY;
RETROSPECTIVE STUDY;
SEIZURE;
SIDE EFFECT;
|
EID: 84884587471
PISSN: 00223050
EISSN: 1468330X
Source Type: Journal
DOI: 10.1136/jnnp-2013-304897 Document Type: Article |
Times cited : (90)
|
References (3)
|